US Stocks
/
Prelude Therapeutics Incorporated Share Price
Prelude Therapeutics Incorporated Share Price

Prelude Therapeutics Incorporated Share Price

NASDAQ: PRLD | Micro Cap
$3.88
+$0.07 (1.97%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Prelude Therapeutics Incorporated Stock Performance

Open
$3.75
Prev. Close
$3.81
Circuit Range
N/A
Day Range
$3.74 - $3.95
Year Range
$1.17 - $6.82
Volume
24,398
Average Traded
$3.88

Prelude Therapeutics Incorporated Share Price Today

As of 9 October 2026, Prelude Therapeutics Incorporated's share price is $3.88. The stock opened at $3.75, compared to its previous close of $3.81. During today's trading session, Prelude Therapeutics Incorporated's share price traded between $3.74 and $3.95, with an average price of $3.85. Over the past 52 weeks, the stock has recorded a high of $6.82 and a low of $1.17. In terms of performance, Prelude Therapeutics Incorporated's share price has declined by 25.24% over the last six months and is up 144.03% on a year-on-year basis.

Prelude Therapeutics Incorporated Share Price Chart

$3.74$3.95
L
Show Current Price
H

Prelude Therapeutics Incorporated Stock Fundamentals & Key Indicators

Market Cap
$298.59M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.76
Revenue (TTM)
$12.14B
Return On Equity (TTM)
-45.23%
Profit Margin
-819.60%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
29.45%

Prelude Therapeutics Incorporated Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$6.50$5.64$4.58$5.70
Net Profit-$19.73-$16.46-$10.39-$13.92
Net Profit Margin-303.54%-291.84%-226.86%-244.21%
Income ChangeN/A16.57%36.88%-33.97%

Prelude Therapeutics Incorporated Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$7.00$12.14
Net Profit-$115.44-$121.83-$127.17-$99.50
Net Profit MarginN/AN/A-1816.71%-819.60%
Income ChangeN/A-5.54%-4.38%21.76%

About Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Prelude Therapeutics Incorporated Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.77
$3.88
-1.02%
Sep 2026
$5.54
$3.92
-38.07%
Aug 2026
$4.61
$6.33
+37.31%
Jul 2026
$5.27
$4.61
-13.26%
Jun 2026
$3.86
$5.32
+35.24%
May 2026
$5.01
$3.93
-24.28%
Apr 2026
$3.60
$5.19
+52.65%
Mar 2026
$2.74
$3.40
+23.19%
Feb 2026
$1.88
$2.76
+48.39%
Jan 2026
$2.80
$1.86
-35.64%
Dec 2025
$1.52
$2.89
+72.54%
Nov 2025
$1.62
$1.68
+5.35%

PRLD Share Price FAQs

What is Prelude Therapeutics Incorporated share price today?

chevron-up
Prelude Therapeutics Incorporated share price today is $3.88 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Prelude Therapeutics Incorporated stock?

chevron-up
The 52 week high of Prelude Therapeutics Incorporated stock is $6.82, while the 52 week low is $1.17 as of 9 Oct '26.

What is PRLD's market capitalisation today?

chevron-up
PRLD market capitalisation is $298.59M as of October 9, 2026, at 5:15 am IST.

What is PRLD's net income for the last quarter?

chevron-up
PRLD's net income for the last quarter is -13.92B USD.

What is the 5 year returns of PRLD?

chevron-up
The 5 year returns of PRLD is -77.93% as on 9 Oct '26.

What is the high & low stock price of PRLD today?

chevron-up
PRLD stock price hit a high of $3.95 and low of $3.74 as of 9 Oct '26.

Can I buy PRLD shares in India?

chevron-up
Yes. You can buy PRLD in India by opening an international trading account.